132 related articles for article (PubMed ID: 27041792)
1. The Serum Concentrations of Chemokine CXCL12 and Its Specific Receptor CXCR4 in Patients with Esophageal Cancer.
Łukaszewicz-Zając M; Mroczko B; Kozłowski M; Szmitkowski M
Dis Markers; 2016; 2016():7963895. PubMed ID: 27041792
[TBL] [Abstract][Full Text] [Related]
2. Higher importance of interleukin 6 than classic tumor markers (carcinoembryonic antigen and squamous cell cancer antigen) in the diagnosis of esophageal cancer patients.
Łukaszewicz-Zając M; Mroczko B; Kozłowski M; Nikliński J; Laudański J; Szmitkowski M
Dis Esophagus; 2012 Apr; 25(3):242-9. PubMed ID: 21895853
[TBL] [Abstract][Full Text] [Related]
3. Serum concentrations of receptor for interleukin 8 in patients with esophageal cancer.
Łukaszewicz-Zając M; Kulczyńska-Przybik A; Muszyński P; Kozłowski M; Szmitkowski M; Mroczko B
Pol Arch Med Wewn; 2016 Oct; 126(11):854-861. PubMed ID: 27906878
[TBL] [Abstract][Full Text] [Related]
4. Serum CXCL12, but not CXCR4, Is Associated with Head and Neck Squamous Cell Carcinomas.
Lavaee F; Zare S; Mojtahedi Z; Malekzadeh M; Khademi B; Ghaderi A
Asian Pac J Cancer Prev; 2018 Apr; 19(4):901-904. PubMed ID: 29693336
[TBL] [Abstract][Full Text] [Related]
5. Serum stromal-derived-factor-1 (CXCL12) and its alpha chemokine receptor (CXCR4) as biomarkers in neonatal sepsis.
Badr HS; El-Gendy FM; Helwa MA
J Matern Fetal Neonatal Med; 2018 Aug; 31(16):2209-2215. PubMed ID: 28562124
[TBL] [Abstract][Full Text] [Related]
6. Expression of CXCL12 and its receptor CXCR4 in esophageal squamous cell carcinoma.
Sasaki K; Natsugoe S; Ishigami S; Matsumoto M; Okumura H; Setoyama T; Uchikado Y; Kita Y; Tamotsu K; Hanazono K; Owaki T; Aikou T
Oncol Rep; 2009 Jan; 21(1):65-71. PubMed ID: 19082444
[TBL] [Abstract][Full Text] [Related]
7. Comparison between clinical significance of serum CXCL-8 and classical tumor markers in oesophageal cancer (OC) patients.
Łukaszewicz-Zając M; Pączek S; Muszyński P; Kozłowski M; Mroczko B
Clin Exp Med; 2019 May; 19(2):191-199. PubMed ID: 30820705
[TBL] [Abstract][Full Text] [Related]
8. Specific Receptors for the Chemokines CXCR2 and CXCR4 in Pancreatic Cancer.
Litman-Zawadzka A; Łukaszewicz-Zając M; Gryko M; Kulczyńska-Przybik A; Kędra B; Mroczko B
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32867211
[TBL] [Abstract][Full Text] [Related]
9. CXCL12-binding receptors expression in non-small cell lung cancer relates to tumoral microvascular density and CXCR4 positive circulating tumoral cells in lung draining venous blood.
Franco R; Pirozzi G; Scala S; Cantile M; Scognamiglio G; Camerlingo R; Botti G; Rocco G
Eur J Cardiothorac Surg; 2012 Feb; 41(2):368-75. PubMed ID: 21683606
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of elevated CXCR4 and CXCL12 in neonatal sepsis.
Tunc T; Cekmez F; Cetinkaya M; Kalayci T; Fidanci K; Saldir M; Babacan O; Sari E; Erdem G; Cayci T; Kul M; Kavuncuoglu S
J Matern Fetal Neonatal Med; 2015 Feb; 28(3):356-61. PubMed ID: 24749796
[TBL] [Abstract][Full Text] [Related]
11. Expression of CXCL12/CXCR4 and its correlation to prognosis in esophageal squamous cell carcinoma.
Wang DF; Lou N; Zeng CG; Zhang X; Chen FJ
Ai Zheng; 2009 Feb; 28(2):154-8. PubMed ID: 19550128
[TBL] [Abstract][Full Text] [Related]
12. Chemokines and their receptors in esophageal cancer--the systematic review and future perspectives.
Łukaszewicz-Zając M; Mroczko B; Szmitkowski M
Tumour Biol; 2015 Aug; 36(8):5707-14. PubMed ID: 26130416
[TBL] [Abstract][Full Text] [Related]
13. Expression of CXCL12 and its receptor CXCR4 correlates with lymph node metastasis in submucosal esophageal cancer.
Sasaki K; Natsugoe S; Ishigami S; Matsumoto M; Okumura H; Setoyama T; Uchikado Y; Kita Y; Tamotsu K; Sakurai T; Owaki T; Aikou T
J Surg Oncol; 2008 Apr; 97(5):433-8. PubMed ID: 18176915
[TBL] [Abstract][Full Text] [Related]
14. CXCL12 and CXCR4 in the Peripheral Blood of Patients with Parkinson's Disease.
Bagheri V; Khorramdelazad H; Hassanshahi G; Moghadam-Ahmadi A; Vakilian A
Neuroimmunomodulation; 2018; 25(4):201-205. PubMed ID: 30428473
[TBL] [Abstract][Full Text] [Related]
15. Expression of chemokine receptor CXCR4 in esophageal squamous cell and adenocarcinoma.
Gockel I; Schimanski CC; Heinrich C; Wehler T; Frerichs K; Drescher D; von Langsdorff C; Domeyer M; Biesterfeld S; Galle PR; Junginger T; Moehler M
BMC Cancer; 2006 Dec; 6():290. PubMed ID: 17176471
[TBL] [Abstract][Full Text] [Related]
16. Involvement of CXCL12 and CXCR4 in lymph node metastases and development of oral squamous cell carcinomas.
Oliveira-Neto HH; Silva ET; Leles CR; Mendonça EF; Alencar Rde C; Silva TA; Batista AC
Tumour Biol; 2008; 29(4):262-71. PubMed ID: 18781098
[TBL] [Abstract][Full Text] [Related]
17. The diagnostic value of the measurement of matrix metalloproteinase 9 (MMP-9), squamous cell cancer antigen (SCC) and carcinoembryonic antigen (CEA) in the sera of esophageal cancer patients.
Mroczko B; Kozłowski M; Groblewska M; Łukaszewicz M; Nikliński J; Jelski W; Laudański J; Chyczewski L; Szmitkowski M
Clin Chim Acta; 2008 Mar; 389(1-2):61-6. PubMed ID: 18155162
[TBL] [Abstract][Full Text] [Related]
18. Chemokine receptor CXCR4 and its ligand CXCL12 expressions and clinical significance in bladder cancer.
Yang DL; Xin MM; Wang JS; Xu HY; Huo Q; Tang ZR; Wang HF
Genet Mol Res; 2015 Dec; 14(4):17699-707. PubMed ID: 26782415
[TBL] [Abstract][Full Text] [Related]
19. Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinoma.
Shimada H; Nabeya Y; Okazumi S; Matsubara H; Shiratori T; Gunji Y; Kobayashi S; Hayashi H; Ochiai T
Surgery; 2003 May; 133(5):486-94. PubMed ID: 12773976
[TBL] [Abstract][Full Text] [Related]
20. Serum matrix metalloproteinase 2 and tissue inhibitor of matrix metalloproteinases 2 in esophageal cancer patients.
Groblewska M; Mroczko B; Kozlowski M; Niklinski J; Laudanski J; Szmitkowski M
Folia Histochem Cytobiol; 2012; 50(4):590-8. PubMed ID: 23264224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
